Advances in oncolytic virotherapy.

Russell, Stephen J; Bell, John C; Engeland, Christine E; McFadden, Grant

Russell, Stephen J; Bell, John C; Engeland, Christine E; McFadden, Grant.

Afiliación

Russell SJ; Mayo Clinic, Rochester, MN USA.
Bell JC; Vyriad, Rochester, MN USA.
Engeland CE; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON Canada.
McFadden G; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Commun Med (Lond) ; 2: 33, 2022.

Article en En | MEDLINE | ID: mdl-35603308

RESUMEN

Recent years have seen rapid advances in the preclinical development and clinical evaluation of oncolytic (cancer-lysing) virus-based therapies, and these are emerging as treatment modality for some cancers. There are challenges to address, however, if we are to maximize the impact of these therapies in patients.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Commun Med (Lond) Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google